Skip to main content
SpringerLink
Log in

Possible molecular basis of cardioprotective effects of green tea

  • Original Article
  • Published:
Mediterranean Journal of Nutrition and Metabolism

Abstract

Clinical data suggest that people who use green tea have a lower cardiovascular risk. However, the exact mechanisms of these cardioprotective effects are unknown. We know that STAT1 plays a critical role in promoting apoptotic cell death and STAT3 may antagonise STAT1 and protect cardiac myocytes from ischaemia/reperfusion (I/R) injury. More recently it has been shown that specific molecules such as epigallocatechin-3-gallate (EGCG), which is present in green tea extract (GTE), have antioxidant properties. Considering that: (i) oxygen free radicals (OFR) are produced during myocardial I/R insult and (ii) OFR are responsible for reperfusion cardiac damage, we therefore investigated whether chronic administration per os of GTE reduced I/R damage in the Langendorff perfused isolated rat heart. In addition we evaluated myocardial content of STAT1 and STAT3 and degree of apoptosis. In Sprague-Dawley isolated hearts, GTE reduced the ischaemic mechanical insult, prolonged STAT3 activation/phosphorylation and reduced STAT1 activation with consequent less cell apoptosis. These results show that chronic treatment with GTE protects the heart from I/R injury. Activation of prosurvival STAT3 over the pro-apoptotic STAT1 could be one of the molecular mechanisms involved in green tea-mediated cardiopretection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Higton JV, Frei B (2003) Tea catechins and polyphenols: health effects, metabolism, and antioxidant function. Crit Rev Food Sci Nutr 43:89–143

    Article  Google Scholar 

  2. Menegazzi M, Tedeschi E, Dussin D et al (2001) Anti-interferon gamma action of epigallocatechin-3-gallate mediated by specific inhibition of STAT1 activation. FASEB J 15:1309–1311

    CAS  Google Scholar 

  3. Scarabelli TM, Stephanou A, Pasini E et al (2002) Different signalling pathways induce apoptosis in endothelial cells and cardiac myocytes during ischaemia/reperfusion injury. Circ Res 90:745–748

    Article  CAS  Google Scholar 

  4. Ferrari R, Cargnoni A, Bernocchi P et al (1996) Metabolic adaptation during a sequence of no-flow and low-flow ischemia: a possible trigger for hibernation. Circulation 94:2587–2596

    CAS  Google Scholar 

  5. Stephanou A, Brar BK, Scarabelli T et al (2000) Ischaemia-induced STAT-1 expression and activation plays a critical role in cardiac myocyte apoptosis. J Biol Chem 275:10002–10008

    Article  CAS  Google Scholar 

  6. Stephanou A, Latchman DS (2005) Opposing actions of STAT-1 and STAT-3. Growth Factor 23:177–182

    Article  CAS  Google Scholar 

  7. Stephanou A, Brar BK, Knight RA, Latchman DS (2000) Opposing actions of STAT-1 and STAT-3 on the Bcl-2 and Bcl-x promoters. Cell Death Differentiation 7:329–330

    Article  CAS  Google Scholar 

  8. Stephanou A, Scarabelli T, Townsend PA et al (2002) The carboxyl-terminal activation domain of the STAT-1 transcription factor enhances ischaemia/reperfusion-induced apoptosis in cardiac myocytes. FASEB J 16:1841–1843

    CAS  Google Scholar 

  9. Stephanou A (2002) Activated STAT-1 pathway in the myocardium as a novel therapeutic target in ischaemia/reperfusion injury. European Cytokine Network 13:387–390

    Google Scholar 

  10. Stephanou A, Scarabelli T, Brar BK et al (2001) Induction of apoptosis and Fas/FasL expression by ischaemia/reperfusion in cardiac myocytes requires serine 727 of the STAT1 but not tyrosine 701. J Biol Chem 276:28340–28347

    Article  CAS  Google Scholar 

  11. Menegazzi M, Tedeschi E, Dussin D et al (2001) Anti-interferon gamma action of epigallocatechin-3-gallate mediated by specific inhibition of STAT1 activation. FASEB J 15:1309–1311

    CAS  Google Scholar 

  12. Townsend PA, Scarabelli TM, Pasini E et al (2004) Epigallocatechin-3-gallate inhibits STAT-1 activation and protects cardiac myocytes from ischemia/reperfusion-induced apoptosis. FASEB J 18:1621–1623

    CAS  Google Scholar 

  13. Roth E (1998) The impact of L-arginine-nitric oxide metabolism on ischaemia/reperfusion injury. Curr Opin Clin Nutr Metab Care 1:97–99

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. “S Maugeri Foundation” IRCCS, Medical Center of Lumezzane, Via Mazzini, Lumezzane (BS), Italy

    E. Pasini

  2. Medical Molecular Biology Unit Institute of Child Health, University College London, London, UK

    A. Stephanou

  3. VA Ann Arbor Health Care System Division of Cardiology, University of Michigan, Ann Arbor, MI, USA

    C. C. Scarabelli

  4. Division of Human Anatomy Department of Biomedical Sciences and Biotechnology, University of Brescia, Brescia, Italy

    G. Corsetti

  5. Metabolic Service and Nutritional Pathophysiology S. Maugeri Foundation, IRCCS, Scientific Institute of Montescano, Pavia, Italy

    R. Aquilani

  6. Center for Heart and Vessel Preclinical Studies St. John Hospital and Medical Center, Wayne State University School of Medicine, Detroit, MI, USA

    T. M. Scarabelli

Authors
  1. E. Pasini
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Stephanou
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. C. Scarabelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G. Corsetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R. Aquilani
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. T. M. Scarabelli
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to E. Pasini.

About this article

Cite this article

Pasini, E., Stephanou, A., Scarabelli, C.C. et al. Possible molecular basis of cardioprotective effects of green tea. Mediterr J Nutr Metab 2, 15–19 (2009). https://doi.org/10.1007/s12349-009-0036-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12349-009-0036-8

Keywords

Search

Navigation